Close Menu

NEW YORK – Bruker said today it has completed debt financing with which it aims to add to its financial flexibility and fund corporate strategic objectives.

The company said the move takes advantage of low interest rates in the US and Europe while fixing rates on roughly 60 percent of its borrowing capacity and extending debt maturities to 2026 and 2029.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.